Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy

Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy

Abstract Background This study was designed to evaluate the effect of progesterone receptor (PR) status on the prognosis of advanced estrogen receptor (ER)-high human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first...

Full description

Bibliographic Details
Main Authors: Lin Jia, Junning Peng, Nan Sun, Hongying Chen, Zhenyu Liu, Wenhui Zhao, Qingyuan Zhang, Liru Li
Format: Article
Language:English
Published: BMC 2024-07-01
Series:BMC Cancer
Subjects:
PR status
ER-high
Breast cancer
POD24
Prognosis
Online Access:https://doi.org/10.1186/s12885-024-12621-y

Internet

https://doi.org/10.1186/s12885-024-12621-y

Similar Items